The combination of Surmontil (amitriptyline), Vivactil (protriptyline), GHB (gamma-hydroxybutyrate), and Clonazepam presents a particularly challenging scenario for those and prescribing professionals. These drug carries its respective hazards , and their combined use can substantially increase the possibility of adverse effects. GHB, in particular